The move towards automation has been a key trend in the pharma and biotech sectors. We’ve seen the robotic handling and processing of samples move from high-throughput screening domains onto the discovery bench. Almost every lab now has a liquid handling or clone/cell-picking robot, and high-content single-cell screening instruments are replacing fluorescence-activated cell sorters. Scientists want to see seamless flows of data from lab instruments into processing, analysis and knowledge platforms. Guest blogger Agnes Huot, former Director of R&D IT at Biogen Idec, explains.